Endotoxin (lipopolysaccharide or LPS), the major constituent of the cell wall of Gram-negative bacteria, induces pro-inflammatory and immunostimulatory responses in various cell types, including macrophages and monocytes. 1 LPS binds to the CD14 receptor, a GPI-linked protein, which lacks a transmembrane domain and is unable to induce cell signaling. It has been recently suggested that the transmembrane transducer associated with the CD14 receptor is the Toll-like receptor (TLR) 4. 2-4 TLR4 couples to post-receptor molecules that also transduce signaling for the IL-1 receptor. These include proteins such as myeloid differentiation factor 88 (MyD88), interleukin-1 receptor associated kinase (IRAK), TNF receptor-activated factor (TRAF) 6 and others. 4-6 Among other post-receptor molecules involved in the LPS signal transduction are the heterotrimeric guanine nucleotide binding regulatory (G) proteins. It has been shown that G i proteins are physically associated with the CD14 receptor. 7 Studies utilizing pertussis toxin (PTx), which inhibits receptor coupling by catalyzing the ADP-ribosylation of G i pro-Previous studies have suggested that heterotrimeric G proteins and tyrosine kinases may be involved in lipopolysaccharide (LPS) signaling events. Signal transduction pathways activated by LPS were examined in human promonocytic THP-1 cells. We hypothesized that G i proteins and Src tyrosine kinase differentially affect mitogen-activated protein (MAP) kinases (MAPK) and nuclear factor kappa (NF-B) activation. Post-receptor coupling to G i proteins were examined using pertussis toxin (PTx), which inhibits G i receptor-coupling. The involvement of the Src family of tyrosine kinases was examined using the selective Src tyrosine kinase inhibitor pyrazolopyrimidine-2 (PP2). Pretreatment of THP-1 cells with PTx attenuated LPS-induced activation of c-Jun-N-terminal kinase (JNK) and p38 kinase, and production of tumor necrosis factor-alpha (TNF-) and thromboxane B 2 (TxB 2 ). Pretreatment with PP2 inhibited TNF-and TxB 2 production, but had no effect on p38 kinase or JNK signaling. Therefore, the G i -coupled signaling pathways and Src tyrosine kinase-coupled signaling pathways are necessary for LPS-induced TNF-and TxB 2 production, but differ in their effects on MAPK activation. Neither PTx nor PP2 inhibited LPS-induced activation of interleukin receptor activated kinase (IRAK) or inhibited translocation of NF-B. However, PP2 inhibited LPS-induced NF-B transactivation of a luciferase reporter gene construct in a concentration-dependent manner. Thus, LPS induction of Src tyrosine kinases may be essential in downstream NF-B transactivation of genes following DNA binding. PTx had no effect on NF-B activation of the reporter construct. These data suggest upstream divergence in signaling through G i pathways leading to MAPK activation and other signaling events leading to I B degradation and NF-B DNA binding.
INTRODUCTION
teins, have demonstrated inhibition of LPS-induced transcription of IL-1 mRNA, activation of mitogen-activated protein (MAP) kinase, and production of prostaglandin E 2 (PGE 2 ), thromboxane B 2 (TxB 2 ), and NO in different cell types. [8] [9] [10] [11] [12] Solomon et al. 7 have shown that a G i protein ligand, mastoparan, inhibits MAP kinase activation and cytokine production. Moreover, it is known that some G i protein-coupled receptors regulate the phosphorylation of the MAP kinases: extracellular signal-regulated kinase (ERK1/2), p38 kinase, and c-Jun N-terminal kinase (JNK) in response to stimuli such as hormones, neurotransmitters, and chemokines. Although the involvement of G i proteins in MAP kinase activation has been shown in other systems, the role of G i in LPS signal transduction pathways has not been fully explored.
Src family tyrosine kinase proteins are frequently associated with the G i proteins in transducing extracellular signals. 13 A number of studies indicate a role of certain Src family kinases in LPS signal transduction, namely Hck, Fgr and Lyn. [14] [15] [16] [17] Knockout mice in the Hck and Fgr proteins showed marked resistance to endotoxin shock 17 and a specific Src family inhibitor pyrazolopyrimidine-1 (PP1) blocked TNF-production and inducible nitric oxide synthase (iNOS). 16 LPS induces the synthesis and release of many pro-and anti-inflammatory mediators through activation of several signaling pathways including ERK, p38, and JNK, which are involved in transcriptional and post-transcriptional regulation. 12, 18, 19 Also, LPS induces cellular pathways that lead to the activation of the transcription factor nuclear factor B (NF-B), which is one of the most important transcription factors involved in early-response gene expression. 20 In response to different stimuli, I B , which detains NF-B in the cytoplasm in unstimulated cells, is phosphorylated and degraded. These events allow nuclear translocation of NF-B that binds to DNA of specific target genes. 20 Although some of these events have been characterized, the precise role of post receptor molecules such as G i protein and Src kinases in LPS-induced MAP kinase and NF-B activation and in mediator production is still not completely understood. In this study, we hypothesized that G i proteins and the Src family of tyrosine kinases differentially affect MAP kinase activity and NF-B DNA activation. Using PTx to block G i protein and PP2, a specific Src tyrosine kinase inhibitor, the modulation of MAP kinases, degradation of I B , DNA binding and transcriptional activity of NF-B, and production of TNF-and TxB 2 were investigated.
MATERIALS AND METHODS

Cell culture
Human promonocytic THP-1 cells were grown in RPMI 1640 medium (Cellgro Mediatech Inc., Herndon, VA, USA), supplemented with 10% fetal calf serum (FCS; Sigma, St Louis, MO, USA), 50 U/ml penicillin, 50 mg/ml streptomycin (Cellgro Mediatech), in 150 cm 2 tissue culture flasks and maintained at 37°C in an incubator (5% CO 2 /95% air). Cells were maintained at a density of 3-5 x 10 5 cells/ml and were used between the third and fifteenth passage. For all experiments, RPMI 1640 medium with 1% FCS, penicillin, and streptomycin was used. The THP-1 cells were undifferentiated; therefore, higher concentrations of LPS were employed for cell activation.
Cell stimulation and experimental protocol
For evaluation of JNK and p38 kinase phosphorylation, I B cellular content, and NF-B DNA binding, THP-1 cells were plated at a density of 5 x 10 6 cells/ml and stimulated with LPS (10 mg/ml) from Salmonella enteritidis (Sigma) for 40 min. Cells were pretreated with pertussis toxin (PTx; List Biological Laboratories, Inc., Campbell, CA, USA) at a concentration of 10-100 ng/ml for 6 h and subsequently stimulated with LPS (10 mg/ml). Cells were pretreated with the pyrazolopyrimidine inhibitor (PP2; Calbiochem-Novabiochem, San Diego, CA, USA) at concentrations between 6.25-25 mM for 1 h followed by LPS (10 mg/ml) stimulation for 40 min. For assessing TNF-and TxB 2 production, THP-1 cells were stimulated with LPS for 24 h with or without pretreatment with the inhibitors.
Western blot analysis
After appropriate stimulation, cells were centrifuged and lysed with ice-cold RIPA lysis buffer (20 mM HEPES, pH 7.4, 1% Triton X-100, 50 mM NaCl, 1 mM EGTA, 5 mM -glycerophosphate, 30 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 0.1 mM phenylmethylsulfonyl fluoride (PMSF), 10 mg/ml leupeptin, and 10 mg/ml pepstatin A). Cells were kept on ice for 10 min, sonicated for 3 s, and centrifuged for 10 min at 4°C at 10,000 g. An aliquot was taken for protein determination using the Bio-Rad Protein Assay (Bio-Rad, Hercules, CA, USA) and the remaining supernatant was stored at -20°C until Western blot analysis was performed.
For detection of I B , JNK, and p38 kinases, lysates were added to Laemmli sample buffer and boiled for 5 min. Subsequently, protein from each sample was subjected to a 12% sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and transferred onto a polyvinylidene difluoride (PVDF) membrane. For immunodetection, membranes were washed with Tris-buffered saline-Tween 20 (TBS-T; 20 mM Tris, 500 mM NaCl, 0.1% Tween 20) and blocked in a 5% powdered milk solution in TBS-T for 1 h. After 3 washes with TBS-T, membranes were incubated for 1 h or overnight with either one of the following polyclonal antibodies in TBS-T: anti-p38 kinase, specific for the dual-phosphorylated form on Thr180/Tyr182 (1:1000; Promega, Madison, WI, USA); anti-JNK, specific for the dual-phosphorylated form on Thr183/Tyr185 (1:1000; Promega); anti-I B , detecting total content of I B (1:1000; Cell Signaling, Beverly, MA, USA). Membranes were washed again before being incubated with a horseradish peroxidase-conjugated donkey anti-rabbit-IgG antibody (1:4000; Amersham Pharmacia Biotech, Inc., Piscataway, NJ, USA) in blocking buffer for 1 h. After the last 3 washes with TBS-T (TBS, Tween-20 0.15%), protein detection was visualized by incubation with ECL Plus detection reagents (Amersham Pharmacia Biotech, Inc.) for 5 min and development of the exposed ECL hyperfilms (Amersham Pharmacia Biotech, Inc.).
Nuclear extraction
Nuclear extracts were isolated by a modified procedure of Dignam et al. 21 Briefly, following treatment, cells were centrifuged at 2800 g for 5 min, resuspended in 400 ml of hypotonic buffer A (10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 0.5 mM PMSF, 1 mM DTT, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml pepstatin A), set on ice for 10 min and vortexed for 4 s with 0.6% Nonidet-P40. Following centrifugation at 2800 g for 10 min at 4°C, the pellet was resuspended in 15 ml of buffer C (20 mM HEPES pH 7.9, 1 M NaCl, 5% glycerol, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.5 mM PMSF, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml pepstatin A) and gently agitated on an orbital shaker at 4°C for 30 min. After centrifugation at 14,000 g for 10 min, an aliquot of each supernatant was taken for protein determination and the remaining supernatant was stored at -70°C.
Electrophoretic mobility shift assay (EMSA)
Double-stranded consensus binding site oligonucleotide for NF-B was obtained from Promega and was endlabeled with [ -32 P]-ATP (NEN Life Science Products, Boston, MA, USA) using T4 polynucleotide kinase (Promega). For binding reactions, 10 mg of nuclear extracts were incubated in 20 ml of total reaction mix (20 mM HEPES pH 7.9, 50 mM KCl, 1 mM EDTA, 5% glycerol, 1 mM DTT, 250 mg/ml bovine serum albumin [BSA]) containing the non-specific competitors pd(N) 6 and poly(dI-dC)-poly(dI-dC; Amersham Pharmacia Biotech). The labeled oligonucleotide was added and the mixture was incubated for 20 min at room temperature. Samples were analyzed by 4% non-denaturing SDS-PAGE. The gel was then dried and exposed to Hyperfilm ECL at -70°C.
Transient transfection and luciferase assay
The pNF-B-Luc reporter plasmid (Stratagene, La Jolla, CA, USA) for evaluation of NF-B-dependent transcription and the pRL-TK (Renilla) vector (Promega) for evaluation of transfection efficiency were used to transfect THP-1 cells using the FuGene 6 Transfection reagent (Roche Diagnostics Corporation, Indianapolis, IN, USA). The ratio pNF-B-Luc reporter DNA:pRL-TK vector DNA was 10:1. For each microgram of total DNA, 3 ml of FuGene reagent was used in medium containing 5% FCS. After a 6-h incubation, the medium was changed for complete and the cells were incubated overnight or for 40 h depending on the experimental protocol. After 18 h, the transfected cells were centrifuged, incubated with PTx or medium alone for 6 h and then stimulated with LPS (10 mg/ml) or medium alone for 14 h. For the experiment with PP2, cells were centrifuged 40 h after transfection, incubated with the inhibitor for 1 h and then stimulated with LPS (10 mg/ml) or medium alone for 6 h. After each experiment, cells were centrifuged and dual-reporter luciferase assays were performed on cell lysates as described in the manufacturer's protocol (Promega). Results were normalized to controls for each experiment and expressed as fold induction. Transfection efficiency varied between 6-8%.
Immunoprecipitation and in vitro kinase assay
After appropriate stimulation, cells were centrifuged and lysed with ice-cold immunopreciptitation lysis buffer (20 mM HEPES pH 7.4, 1% Nonidet P-40, 150 mM NaCl, 1 mM EDTA, 1 mM benzamidine, 10 mM p-nitrophenylphosphate, 1 mM sodium fluoride, 1 mM sodium orthovanadate, 1 mM PMSF, 1 mM dithiothritol, 1 mg/ml leupeptin, 1 mg/ml aprotinin, and 1 mg/ml pepstatin A). Cells were kept on ice for 10 min, sonicated for 3 s, and centrifuged for 10 min at 4°C at 10,000 g. An aliquot was taken for protein determination using the Bio-Rad Protein Assay (Bio-Rad) and the remaining supernatant was stored at -20°C until Western blot analysis was performed. Lysates were incubated with antibody to IRAK protein (5 mg/sample) for 3 h at 4°C on a rotator. The lysates were then incubated with 50 ml of protein G-Sepharose beads overnight at 4°C on a rotator. The lysates were washed 4 times with immunoprecipitation lysis buffer and centrifuged for 1 min at 4000 rpm in a microcentrifuge after each wash. After the final wash, 150 ml of immunoprecipitation lysis buffer was added. Then 300 ml of Laemmli sample buffer was added and the samples were boiled for 4 min. Half of the samples were collected for Western blot analysis as described previously and half of the samples were used for in vitro kinase assays.
For the in vitro kinase assays, the samples were incubated with 5 mM ATP, 20-50 mCi [ -32 P]-ATP, and 1 mg myelin basic protein (MBP) for 30 min at 37°C. The reactions were promptly stopped by addition of 100 ml Laemmli sample buffer and rapid boiling for 4 min. Samples were electophoresed as described for Western blots and assessed by radiography.
TNF-assay
TNF-was measured using an enzyme-linked immunosorbant assay (ELISA). Briefly, anti-human TNF-antibody (0.8 mg/ml; R&D System Inc., Minneapolis, MN, USA) was used to coat 96-well enhanced-binding plates overnight at 4°C. The plates were washed with PBS/Tween-20 and blocked for 2 h with blocking buffer containing 10% BSA. Plates were washed, standards and samples were added and incubated overnight at 4°C. After washing, biotinylated anti-human TNF-antibody (0.3 mg/ml; R&D System Inc.) was added to the wells and plates were incubated for 1 h at room temperature. Plates were washed, streptavidin-peroxidase conjugate (1:2000; BioSourse International Inc., Camarillo, CA, USA) was added and plates were incubated for 45 min. Finally, after washing, the ABTS substrate solution containing 3% H 2 O 2 was added and plates were read at 415 nm within 1 h. The lowest detectable TNF-concentration with the assay was 10 pg/ml.
TxB 2 assay
After treatment, cells were centrifuged and supernatants were stored at -20°C. Samples were diluted 1:10 in buffer containing 0.1% polyvinylpyrolidine, 0.9% NaCl, 50 mM Tris base, 1.7 mM MgSO 4 , and 0.16 mM CaCl 2 (pH 7.4) prior to radio-immunoassay. TxB 2 was quantitated by radio-immunoassay as previously described. 22 The lowest detectable TxB 2 concentration with the assay was 50 pg/ml.
Data analysis
Gels were analyzed by scanning densitometry and analysis was performed on a Macintosh computer using a public domain NIH Image program (developed at the US National Institutes of Health and available on the Internet at http://rsb.info.nih.gov/nih-image/). Statistical significance was determined by one-way analysis of variance (ANOVA) with Fisher's post-hoc correction using Statview software (SAS Institute Inc., Cary, NC, USA) A value of P < 0.05 was considered significant. Data are expressed as mean ± SEM.
RESULTS
Effects of pertussis toxin on MAPK and NF-B activation
To investigate the role of G i protein in LPS-induced JNK phosphorylation, THP-1 cells were pretreated with 430 Ferlito, Romanenko, Guyton, Ashton, Squadrito, Halushka, Cook PTx (10 and 100 ng/ml), which inhibits G i receptor coupling. After 6 h pretreatment with PTx, cells were stimulated with LPS at a concentration of 10 mg/ml for 40 min. No JNK phosphorylation was detected in control cells (Fig. 1A) . Stimulation with LPS induced a significant phosphorylation of the 54 kDa JNK protein. Pretreatment with PTx decreased LPS-induced JNK phosphorylation to levels similar to those found in the basal group which did not receive LPS stimulation. Phosphorylation of p38 induced by LPS stimulation was attenuated by pretreatment with PTx at both concentrations employed (Fig. 1B) .
The effect of pretreatment with PTx on I B degradation and NF-B DNA binding was also examined. Western blot analysis was carried out to evaluate the total protein content (soluble fraction) of I B (Fig.  1C ). LPS stimulation resulted in a significant degradation (93.1 ± 4.2%; P < 0.05) of I B as compared to the control. In contrast to the effects of PTx on JNK and p38, pretreatment with PTx did not interfere with LPSinduced I B degradation at either concentration. Nuclear extracts from cells stimulated with LPS with or without PTx pretreatment were subjected to EMSA. LPS stimulation resulted in a significant increase in NF-B DNA binding. These studies also demonstrated that LPS-induced NF-B DNA binding was not inhibited by pretreatment with PTx (Fig. 1D) .
Effects of the Src family tyrosine kinase inhibitor, PP2, on MAPK and NF-B activation
It has been shown that the PP2 has specific inhibitor effects on the Src family of tyrosine kinases. 23 THP-1 cells were pretreated with PP2 at concentrations of 6.25-25 mM for 1 h and then stimulated with LPS for 40 min. LPS-induced JNK and p38 phosphorylation was not inhibited by pretreatment with PP2 even at the concentration of 25 mM ( Fig. 2A,B) . Nuclear extracts were examined for NF-B DNA binding after pretreatment with PP2 followed by LPS stimulation. Figure 2C shows that LPS-induced NF-B DNA binding was not inhibited when THP-1 cells were pretreated with the Src kinase inhibitor.
Effects of the Src family tyrosine kinase inhibitor, PP2, on NF-B-dependent transcription
The pNF-B-Luc reporter plasmid was used for evaluation of NF-B-dependent transcription. After transient transfection, THP-1 cells were incubated with PP2 for 1 h and stimulated with LPS or medium alone for 6 h. The inhibitor PP2 reduced LPS-induced NF-B-dependent transcription of reporter gene in a concentration-dependent manner. PP2 at concentrations of 6.25, 25 and 50 Implication of G i proteins and Src tyrosine kinases in LPS signaling events 431 mM resulted in a reduction of 34.1%, 50.3% and 58.2% in activity, respectively (Fig. 3A) . However, pretreatment cells with PTx did not result in any significant changes of luciferase activity induced by LPS stimulation (Fig. 3B ).
Effect of PTx and PP2 on IRAK activation
In subsequent studies of PTx and PP2 on TLR, upstream signaling molecules of NF-B activation were evaluated. THP-1 cells were incubated with PTx or PP2 and IRAK activation was evaluated by the ability of IRAK to phosphorylate myelin basic protein (MBP). LPS induced a significant (P < 0.001, n = 6) increase in IRAK activation compared to basal cells (Fig. 4) . Similarly, IRAK activation in PTx (n = 5) or PP2 (n = 4) treated basal cells were significantly less (P < 0.05) than LPS-stimulated controls. However, neither PTx (n = 4) nor PP2 (n = 4) significantly altered LPS-induced IRAK activation.
Effects of PTx on mediator production
The effects of pretreatment with PTx on LPS-induced TNF-and TxB 2 production were evaluated. THP-1 cells were incubated with PTx for 6 h and then stimulated with LPS for 24 h. TNF-production (65 ± 0.2 pg/ml in control cells) was significantly (P < 0.05) increased (4810 ± 1350 pg/ml) after LPS stimulation (Fig. 4A ). PTx inhibited (P < 0.05) LPS-induced TNFproduction in a concentration-dependent manner to 2010 ± 400 pg/ml and to 800 ± 210 pg/ml at concentrations of 10 and 100 ng/ml, respectively. Also, LPS-induced TxB 2 production was significantly reduced (40 ± 8.5%, n = 3, P < 0.05) by pretreatment with 100 ng/ml PTx (Fig. 4B) . 
Effects of the Src family tyrosine kinase inhibitor, PP2, on mediator production
After pretreatment with the PP2 inhibitor for 1 h, cells were stimulated with LPS for 24 h for determination of TNF-and TxB 2 production (Fig. 5A ). Pretreatment with PP2 inhibited significantly (n = 3, P < 0.05) LPSinduced TNF-production in a concentration-dependent manner. Inhibition of LPS-induced TNF-production was from 38 ± 11% to 77 ± 6% in cells pretreated with 6.25 mM or 50 mM PP2, respectively (P < 0.05). Stimulation of THP-1 cells with LPS induced a significant increase in TxB 2 production (P < 0.05; Fig. 6B ). When cells were pretreated with PP2, LPS-induced TxB 2 production was inhibited (P < 0.05) at all concentrations employed.
DISCUSSION
These studies demonstrate that LPS activation of THP-1 cells induces divergent signaling through post-receptor G i -coupled pathways and pathways leading to I B degradation and NF-B translocation. PTx, which inhibits G i receptor-coupling through ADP-ribosylation, attenuated LPS-induced p38 activation and TxB 2 production, and blocked JNK activation and TNF-production. However, the specific Src tyrosine kinase inhibitor PP2 did not inhibit JNK and p38 kinase phosphorylation but did inhibit TNF-and TxB 2 production. Neither PP2 nor PTx blocked LPS-induced IRAK activation or NF-B translocation and PTx did not inhibit I B degradation. Our previous studies have also demonstrated that PTx blocks LPS-induced p38 activation but not I B degradation in Chinese hamster ovary (CHO) cells stably transfected with CD14. 12 The G i protein ligand, mastoparan, potentiated LPS-induced activation of p38 kinase. 12 Evidence linking CD14 receptor signaling to G i proteins and Src family tyrosine kinase was provided by the studies of Solomon et al. 7 In vitro kinase assays performed on human CD14 co-immunoprecipitated proteins demonstrated the presence of multiple tyrosine Implication of G i proteins and Src tyrosine kinases in LPS signaling events 433 phosphorylated proteins identified as Src family tyrosine kinases, G i2 and G i3 proteins. Mastoparan antagonized LPS activation of MAP kinases, production of TNF-and IL-6, and protected rats from LPS shock. Other studies in a variety of cell types have shown that PTx inhibits IL-1 mRNA transcription and PGE 2 , TxB 2 and NO production. 8, 9, 12, [24] [25] [26] The G i protein subunits involved in LPS activation remain to be clearly defined. However, transfection with constitutively activated mutant G i2 in P388D cells stimulates Ca 2+ influx qualitatively similar to LPS and potentiates LPS-induced arachidonic acid release. 27 There is also considerable evidence that Src family kinases in macrophages are activated in response to LPS. [14] [15] [16] [17] It is thus surprising that Hck -/-Fgr -/-Lyn -/mice exhibit unimpaired nitrite, IL-1 and TNF-production in response to LPS stimulation. 28 However, Hck -/and Fgr -/mice are more resistant to lethal LPS shock. 17 On the other hand, Orlicek et al. 16 demonstrated that the selective Src family tyrosine kinase inhibitor pyrazolopyrimidine (PP1) was a potent inhibitor of LPSinduced TNF-and iNOS expression in RAW 264.7 murine macrophages. Also, in peripheral blood monocytes, PP1 inhibited LPS-induced adhesion and spreading. 29 These events were associated with inhibition of tyrosine phosphorylation of the focal adhesion kinase PyK2 and the cytoskeletal protein, paxillin. In the present study, the Src tyrosine kinase inhibitor, PP2, effectively inhibited TNF-and TxB 2 production, but had no effect on upstream signaling. However, PP2 did block NF-B-induced gene activation suggesting a role of Src tyrosine kinases in transcriptional control.
Studies have suggested another branching signaling pathway. 30 Such a pathway may involve tyrosine phosphorylation of TLR followed by activation of phosphatidylinositol-3 kinase (PI-3-K), the low molecular weight protein Rac and a protein kinase B (AKT). The latter kinase phosphorylates the p65 component of NF-B which promotes the ability of NF-B to induce gene transactivation. Since Src tyrosine kinases have been implicated in PI-3-K activation in other systems, 31 they may be a potential pathway blocked by PP2.
Many studies have shown that inhibitors of NF-B or transfection of the dominant negative mutants of p65 subunit of NF-B inhibit LPS-induced TNF-production. 32 However, our data demonstrate that PP2 and PTx effectively blocked TNF-and TxB 2 production without affecting NF-B translocation. These seemingly conflicting data regarding the importance of NF-B in LPS activation may be a consequence of the imprecise relationship between I B degradation and NF-B DNA binding and gene transactivation. 33, 34 NF-B reporter gene activation in human alveolar cells can be suppressed by a phospholipase C or protein kinase C inhibitor, but IL-1 -induced I B degradation and NF-B DNA binding were unaffected. 35 Also, the tyrosine kinase inhibitor, genistein, blocked LPS-induced NF-B gene transactivation without affecting NF-B translocation. 34 Both PP1 and genistein inhibited IL-1 -and TNF--induced NF-B-dependent transcription in U937 monocytic cells without affecting DNA binding. 33 The latter results are qualitatively similar to our results with PP2 which effectively blocked LPS-induced NF-B transactivation of a luciferase reporter gene construct, but did not affect I B degradation and NF-B binding.
Neither PTx nor PP2 significantly affected upstream TLR signaling as determined by LPS-induced IRAK activation. These data suggest that G i proteins and/or Src tyrosine kinases may comprise a branching pathway downstream of IRAK such as at TRAF-6. On the other hand, these signaling proteins may function upstream of IRAK or may be independent of MyD88 signaling. MyD88-independent pathways have been demonstrated. 36 Alternatively, TLRindependent receptor such as the -integrin receptors known to be G i coupled 37 may be involved in LPS signaling in the THP-1 cells.
Specific inhibitors of signaling proteins may be of therapeutic value in endotoxemia and sepsis. The G i protein ligand, mastoparan, has been shown to improve survival of rats to LPS shock. 7 A class of tyrosine kinase inhibitors, designated tyrphostins, protect rats against LPS shock, 38, 39 Gram-positive sepsis, 38 and murine and canine Escherichia coli peritonitis. 40, 41 The p38 kinase inhibitor SB 203580 has been shown to markedly improve survival of mice subjected to sepsis by cecal ligation puncture. 42 Further investigation of the proximal signaling pathways to LPS may give rise to novel therapeutic approaches to treat sepsis.
